Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2012-09-07

FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)

View source ↗

Summary

FDA approved a supplemental application for CLOBEX (clobetasol propionate) from Galderma Laboratories, L.P. The approval updates the product labeling, potential…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBEX (clobetasol propionate)

Snippet

SUPPL AP for CLOBEX (CLOBETASOL PROPIONATE)